198 related articles for article (PubMed ID: 14611109)
1. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study.
Conrozier T; Bertin P; Mathieu P; Charlot J; Bailleul F; Treves R; Vignon E; Chevalier X
Clin Exp Rheumatol; 2003; 21(5):605-10. PubMed ID: 14611109
[TBL] [Abstract][Full Text] [Related]
2. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis.
Migliore A; Tormenta S; Martin LS; Valente C; Massafra U; Granata M; Alimonti A
Clin Rheumatol; 2005 Jun; 24(3):285-9. PubMed ID: 15592903
[TBL] [Abstract][Full Text] [Related]
3. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline.
Brander V; Skrepnik N; Petrella RJ; Jiang GL; Accomando B; Vardanyan A
Osteoarthritis Cartilage; 2019 Jan; 27(1):59-70. PubMed ID: 30223023
[TBL] [Abstract][Full Text] [Related]
5. Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study.
Conrozier T; Bertin P; Bailleul F; Mathieu P; Charlot J; Vignon E; Treves R; Chevalier X
Joint Bone Spine; 2006 Dec; 73(6):705-9. PubMed ID: 16997602
[TBL] [Abstract][Full Text] [Related]
6. Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice.
Migliore A; Tormenta S; Massafra U; Bizzi E; Iannessi F; Alimonti A; Granata M
Curr Med Res Opin; 2008 May; 24(5):1309-16. PubMed ID: 18373891
[TBL] [Abstract][Full Text] [Related]
7. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?
Conrozier T; Vignon E
Clin Exp Rheumatol; 2005; 23(5):711-6. PubMed ID: 16173254
[TBL] [Abstract][Full Text] [Related]
8. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up.
Migliore A; Tormenta S; Martin Martin LS; Iannessi F; Massafra U; Carloni E; Monno D; Alimonti A; Granata M
Clin Rheumatol; 2006 May; 25(3):389-93. PubMed ID: 16249827
[TBL] [Abstract][Full Text] [Related]
9. Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice.
Conrozier T; Couris CM; Mathieu P; Merle-Vincent F; Piperno M; Coury F; Belin V; Tebib J; Vignon E
Arch Orthop Trauma Surg; 2009 Jun; 129(6):843-8. PubMed ID: 19011882
[TBL] [Abstract][Full Text] [Related]
10. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
Waddell DD; Cefalu CA; Bricker DC
Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis.
Tikiz C; Unlü Z; Sener A; Efe M; Tüzün C
Clin Rheumatol; 2005 Jun; 24(3):244-50. PubMed ID: 15647968
[TBL] [Abstract][Full Text] [Related]
12. Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy.
Huskin JP; Vandekerckhove B; Delincé P; Verdonk R; Dubuc JE; Willems S; Hardy P; Blanco FJ; Charrois O; Handelberg F
Knee Surg Sports Traumatol Arthrosc; 2008 Aug; 16(8):747-52. PubMed ID: 18536906
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and safety of two different molecular weight (MW) hyaluronans F60027 and Hylan G-F20 in symptomatic osteoarthritis of the knee (KOA). Results of a non inferiority, prospective, randomized, controlled trial.
Maheu E; Zaim M; Appelboom T; Jeka S; Trc T; Berenbaum F; Maasalu K; Berenbaum F
Clin Exp Rheumatol; 2011; 29(3):527-35. PubMed ID: 21722501
[TBL] [Abstract][Full Text] [Related]
14. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.
Chevalier X; Jerosch J; Goupille P; van Dijk N; Luyten FP; Scott DL; Bailleul F; Pavelka K
Ann Rheum Dis; 2010 Jan; 69(1):113-9. PubMed ID: 19304567
[TBL] [Abstract][Full Text] [Related]
15. [18-month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis].
Migliore A; Tormenta S; Massafra U; Martin Martin LS; Carloni E; Padalino C; Alimonti A; Granata M
Reumatismo; 2006; 58(1):39-49. PubMed ID: 16639487
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of hylan G-F 20 for symptomatic glenohumeral osteoarthritis: a prospective, pilot study.
Brander VA; Gomberawalla A; Chambers M; Bowen M; Nuber G
PM R; 2010 Apr; 2(4):259-67. PubMed ID: 20430327
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study.
Caglar-Yagci H; Unsal S; Yagci I; Dulgeroglu D; Ozel S
Rheumatol Int; 2005 Jun; 25(5):341-4. PubMed ID: 15004721
[TBL] [Abstract][Full Text] [Related]
18. Hip viscosupplementation under ultra-sound guidance riduces NSAID consumption in symptomatic hip osteoarthritis patients in a long follow-up. Data from Italian registry.
Migliore A; Granata M; Tormenta S; Laganà B; Piscitelli P; Bizzi E; Massafra U; Alimonti A; Maggi C; De Chiara R; Iannessi F; Sanfilippo A; Sotera R; Scapato P; Carducci S; Persod P; Denaro S; Camminiti M; Pagano MG; Bagnato G; Iolascon G
Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):25-34. PubMed ID: 21381497
[TBL] [Abstract][Full Text] [Related]
19. [Intra-articular treatment with Hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up].
Migliore A; Tormenta S; Valente C; Massafra U; Martin Martin LS; Carmenini E; Bernardini A; Alimonti A
Reumatismo; 2005; 57(1):36-43. PubMed ID: 15776145
[TBL] [Abstract][Full Text] [Related]
20. Duration of symptom relief after intra-articular injection of hyaluronic acid combined with sorbitol (anti-ox-vs) in symptomatic hip osteoarthritis.
Migliore A; Massafra U; Bizzi E; Tormenta S; Cassol M; Granata M
Int J Immunopathol Pharmacol; 2014; 27(2):245-52. PubMed ID: 25004836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
